Bone marrow mesenchymal stem cell transplantation in the amelioration of heart function in patients with myocardial infarction

Wang DM,Qiao YF

DOI: https://doi.org/10.3321/j.issn:1673-8225.2007.46.039

2007-01-01

Abstract:BACKGROUND: Currently, interventional therapy can ameliorate myocardial ischemia, but necrotic myocardium cannot actively repair. Recently, stem cell transplantation has been the hot research in the treatment of ischemic heart diseases. Mesenchymal stem cells have been reconstructed with the characteristics of easy material collection, low immunologic rejection, multi-directional differentiation and no ethics problems. OBJECTIVE: To summarize the research progress of bone marrow mesenchymal stem cell transplantation for myocardial infarction. RETRIEVE STRATEGY: The Pubmed Database was undertaken to identify the relevant articles on bone marrow mesenchymal stem cell transplantation for myocardial infarction published from January 1990 to December 2007 with the key words of "Mesenchymal stem cells, transplantation,myocardial infarction" in English. Simultaneously, the Wanfang Database was also searched for relevant articles published from March 2002 to March 2007 with the same key words in Chinese. The data were primarily searched. Inclusive criteria included ①articles on bone marrow mesenchymal stem cell transplantation for myocardial infarction, and ②articles in the same circle published in the authoritative journals or recently published. Exclusive criteria included articles on repetitive studies. LITERATURE EVALUATION: The articles were randomized controlled trials on bone marrow mesenchymal stem cell transplantation for myocardial infarction. Of the 31 articles, 7 were review, and others were clinical or basic experimental studies. DATA SYNTHESIS: ①Bone marrow stem cells have higher plasticity, can move to the injured myocardium after myocardial infarction, differentiate into cardiomyocytes and vascular endothelial cells, and participate in the regeneration of necrotic myocardium. ②Clinical studies verified that bone marrow stem cell transplantation could improve heart function in patients with myocardial infarction. ③Studies on bone marrow mesenchymal stem cells in the repair of cartilage have made great progresses. But there are many problems, for example, the measurement of transplanted cell survival rate; the method of elevating survival rate; how large the infarcted area is to have an effective cellular transplantation; a technique that can label transplanted cells for a long term; the condition of successfully transplanted cells; the determination of optimal transplanted time and transplanted amount; improved transplanted methods, and so on. CONCLUSION: Studies on bone marrow mesenchymal stem cells improving heart function in patients with myocardial infarction, and cell transplantation methods have had great progresses, but many problems are still existed.